Adam
Farren

Before Adam Farren ever stepped into a startup, he stood at a whiteboard drawing plays. He was a high school teacher and basketball coach - the kind of job that trains you in rapid feedback loops, managing limited resources, and communicating clearly under pressure. Skills that, it turns out, transfer directly to scaling software companies in one of the least forgiving verticals in tech.

Farren didn't arrive at healthcare through a bloodline connection to medicine or a family business handed down. He arrived through a door that most people walk right past: he could sell mission-driven software to physicians without making them feel sold to. At Elation Health, the primary care-focused EHR, he took the company's user base, team, and revenue to 20x. Not 20%. Twenty times. That kind of result turns heads across a small but consequential industry.

His is a career defined by a single insight he recognized on his first day at Elation Health: the connection between adding one new customer and improving the lives of clinicians - and by extension, their patients - is unusually direct. Unlike enterprise SaaS where success is measured in NPS scores and logo slides, every physician practice that adopts a better EMR is a doctor who has more time, less cognitive load, and better data. That clarity of purpose is rare. Farren found it early and didn't let go.

When Adam Farren joined Canvas Medical as President and COO in April 2023, the company was already the best-kept secret in healthcare tech - an EMR designed not just for clinicians but for developers. Canvas called itself the "Tesla of EMRs." Farren's job was to make sure the rest of the market found out.

Canvas was founded in 2015 by Andrew Hines and Jim Martineau around a radical premise: that an electronic medical record should be programmable - a platform, not a product. That a physician-owned clinic in Oregon should be able to customize its clinical workflows the same way a fintech startup customizes its payment flow. No vendor lock-in. No drop-down hell. Just open, composable infrastructure.

Farren didn't just close deals. He built the architecture for Canvas to grow. Sales, marketing, customer success, partnerships, and business operations - all under one unified commercial motion. He was the third executive role of his career in the EMR space, but the first time he was betting on a genuinely different kind of company. "The ideal EMR is programmable and extensible, allowing customization to your own care model and integration across the ecosystem," he said on joining.

Sixteen months later, in September 2024, Canvas founder Andrew Hines stepped into the CTO role and handed the keys to Farren. The move was a signal, not a transition - Hines wanted to build. Farren's job was to scale what Hines built into something the whole ambulatory care market couldn't ignore. By then, over 75% of Canvas customers had made AI agents their top priority. The timing was precise.

Farren has a specific critique of legacy EMRs that goes beyond the usual complaint about slow software and bad UX. "Legacy EMRs are built for compliance and billing capture, and use outdated paradigms in architecture and user experience design," he wrote in 2025. "They can't build breakout software businesses." That's not a positioning statement. It's a structural argument about why incumbents can't compete in the coming agentic era.

Canvas's thesis is that AI in healthcare only works when it has full access to real-time patient context, an event-driven architecture, and genuine control over clinical workflows - not just a transcript of what the doctor said. Hyperscribe, the open-source AI copilot Canvas launched in March 2025, was built on exactly this premise. It doesn't just transcribe. It captures structured data, connects to the complete patient record, and chains tasks together - a referral can trigger eligibility verification, which triggers insurance pre-auth, which feeds into the clinical decision support layer. All in real time.

What makes this unusual is the transparency play. Canvas published not just the tool but the evaluation code, the test datasets, and a growing benchmark comparing Hyperscribe against competing AI scribes. In a world where AI healthcare vendors trumpet capability without accountability, Farren is asking customers to hold him to a standard - and making it technically possible to do so.

The pricing model follows the logic. Canvas is moving from seat-based licensing to credit-based pricing tied to outcomes - the same shift happening at Clay, Snowflake, and Salesforce as AI agents replace workflows rather than merely supporting them. When the software does the work, the economics change. Farren saw this coming early enough to architect around it.

Farren credits three things for his trajectory: his ability to communicate clearly (a direct inheritance from the classroom), a determination he built from scratch when he taught himself enterprise sales, and a bias toward action that makes him uncomfortable with problems that don't yet have owners.

That last quality - the refusal to let a problem live without a solution owner - is visible in how Canvas approaches both product and market. Farren doesn't wait for customers to ask for AI agents. He tells them what's coming, builds the evaluation framework publicly, and changes the pricing model before the market forces him to. Moving before the move is required is not the same as moving recklessly. It requires having done the reading.

His aspiration, stated plainly in public interviews, is larger than Canvas Medical's roadmap: accessible, affordable health insurance for every American. That's not a product feature. It's a reason to stay in a hard industry when the complexity is suffocating. He found his "why" at Elation Health on day one and has been building toward it ever since.